Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Danaher Corporation (DHR) vs SpaceX (SPCX) Price & Performance

Danaher CorporationTrade
SpaceXTrade

Price performance (Past 24H)

Key statistics

Danaher Corporation vs SpaceX — how do they compare? Danaher Corporation trades at $198.96 (market cap $140.88B), while SpaceX trades at $137.66 (market cap $1.79T). The key difference: SpaceX is far larger — about 12.7× Danaher Corporation's market cap, and Danaher Corporation pays a 0.8% dividend while SpaceX pays none. Which is the better fit depends on your goals.

DHRSPCX
Market Cap
$140.88B$1.79T
Sector
HealthTechnology
52-Week High
$242.05$202.09
52-Week Low
$161.91$135.00
Enterprise Value
$153.66B$1.81T
Dividend Yield
0.8%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Danaher Corporation

Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.

The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.

SpaceX

SpaceX (SPCX) trades at $139.14, down 4.33% with bearish technical signals despite analyst optimism. The stock shows weak fundamentals with negative profitability (-45% net margin) and extreme valuations (P/S 92.17, EV/EBITDA 957.25). Recent Q1 2026 earnings missed expectations, though inclusion in the Nasdaq-100 provides institutional support. Cash flow remains positive primarily from financing activities.

Long-term growth potential in space economy contrasts with current overvaluation and execution risks. Analyst consensus remains bullish with $239.23 price target, but investors face volatility from high valuations and geopolitical tensions. The stock presents high-risk speculation on future space dominance rather than current fundamentals.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Danaher Corporation

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.

Read more on DHR

About SpaceX

SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.

Read more on SPCX